These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15155235)

  • 21. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
    Cavusoglu C; Karaca-Derici Y; Bilgic A
    Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis.
    McCammon MT; Gillette JS; Thomas DP; Ramaswamy SV; Graviss EA; Kreiswirth BN; Vijg J; Quitugua TN
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2200-9. PubMed ID: 15917513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
    J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
    Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
    J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene.
    Hellmark B; Unemo M; Nilsdotter-Augustinsson A; Söderquist B
    Clin Microbiol Infect; 2009 Mar; 15(3):238-44. PubMed ID: 19196261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environmental regulation of biofilm development in methicillin-resistant and methicillin-susceptible Staphylococcus aureus clinical isolates.
    Fitzpatrick F; Humphreys H; O'Gara JP
    J Hosp Infect; 2006 Jan; 62(1):120-2. PubMed ID: 16221507
    [No Abstract]   [Full Text] [Related]  

  • 27. Helenalin reduces Staphylococcus aureus infection in vitro and in vivo.
    Boulanger D; Brouillette E; Jaspar F; Malouin F; Mainil J; Bureau F; Lekeux P
    Vet Microbiol; 2007 Jan; 119(2-4):330-8. PubMed ID: 17010538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telavancin: in vitro activity against staphylococci in a biofilm model.
    Gander S; Kinnaird A; Finch R
    J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
    Lee JY; Ko KS; Peck KR; Oh WS; Song JH
    J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
    Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N
    J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct continuous method for monitoring biofilm infection in a mouse model.
    Kadurugamuwa JL; Sin L; Albert E; Yu J; Francis K; DeBoer M; Rubin M; Bellinger-Kawahara C; Parr TR; Contag PR
    Infect Immun; 2003 Feb; 71(2):882-90. PubMed ID: 12540570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased tolerance of Staphylococcus aureus to vancomycin in viscous media.
    Kostenko V; Ceri H; Martinuzzi RJ
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):277-88. PubMed ID: 17727657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.
    Smith K; Perez A; Ramage G; Gemmell CG; Lang S
    Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Silvestri C; Renzone G; Testa I; Mocchegiani F; Della Vittoria A; Saba V; Scaloni A; Scalise G
    J Biomed Mater Res A; 2007 Apr; 81(1):233-9. PubMed ID: 17120214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions.
    Sauer K; Steczko J; Ash SR
    J Antimicrob Chemother; 2009 May; 63(5):937-45. PubMed ID: 19282330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo monitoring of Staphylococcus aureus biofilm infections and antimicrobial therapy by [18F]fluoro-deoxyglucose-MicroPET in a mouse model.
    Garrido V; Collantes M; Barberán M; Peñuelas I; Arbizu J; Amorena B; Grilló MJ
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6660-7. PubMed ID: 25155589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices.
    Edmiston CE; Goheen MP; Seabrook GR; Johnson CP; Lewis BD; Brown KR; Towne JB
    Am J Surg; 2006 Sep; 192(3):344-54. PubMed ID: 16920429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo.
    Davis SC; Ricotti C; Cazzaniga A; Welsh E; Eaglstein WH; Mertz PM
    Wound Repair Regen; 2008; 16(1):23-9. PubMed ID: 18211576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci.
    Domenico P; Gurzenda E; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Korem M; Saba V; Scalise G; Balaban N
    Peptides; 2004 Dec; 25(12):2047-53. PubMed ID: 15572191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium inhibits bap-dependent multicellular behavior in Staphylococcus aureus.
    Arrizubieta MJ; Toledo-Arana A; Amorena B; Penadés JR; Lasa I
    J Bacteriol; 2004 Nov; 186(22):7490-8. PubMed ID: 15516560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.